The additional presentation is approved for the treatment of pediatric patients aged 6 to 17 years with plaque psoriasis or ...

Discover a study that analysed evidence showing that metabolic disturbances can also exacerbate psoriasis symptoms. Learn ...

Compared with adalimumab, several biologic medications had superior safety profiles for the treatment of moderate to severe psoriasis.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in high-impact areas.

However, this new study, led by researcher Hye Sun Gwak, reviewed data from 13 different studies and found that some of these ...

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic ...

Patients with psoriatic arthritis (PsA) have a higher prevalence of diabetes mellitus (DM) compared to the general population ...

A recent study reveals a link between belly fat and psoriasis, especially in women. Researchers analyzed data from UK Biobank ...

A rare case of adalimumab-induced pustular psoriasis in a hidradenitis suppurativa patient was successfully treated with ...

The autoimmune disease causes raised, scaly patches of skin. As a child, it left the football star embarrassed to remove his ...

A new study reveals that abdominal fat, more than overall body fat, significantly increases psoriasis risk—especially in ...

Researchers from King’s College London evaluated 25 different measurements of body fat and found that those related to the ...